Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.2 USD | +10.90% | +26.81% | +179.66% |
May. 07 | Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating | MT |
May. 06 | Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+179.66% | 667M | |
+26.67% | 49.18B | |
+0.62% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.75% | 26.09B | |
-22.41% | 18.71B | |
+8.05% | 13.26B | |
+32.05% | 12.32B | |
+0.24% | 11.99B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- Transcript : Stoke Therapeutics, Inc. - Shareholder/Analyst Call